HRMY Q1 2021 Earnings — Harmony Biosciences Holdings, Inc. Revenue & Financial Results | Market Cap Arena

HRMYHarmony Biosciences Holdings, Inc.

$2B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$60M+200.8% YoY

Gross Profit

$49M82.6% margin

Operating Income

$15M24.4% margin

Net Income

$7M12.4% margin

EPS (Diluted)

$0.13

QoQ Revenue Growth

+6.0%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$337M

Total Liabilities

$229M

Stockholders' Equity

$108M

Cash & Equivalents

$141M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$60M	$20M	+200.8%
Gross Profit	$49M	$16M	+201.0%
Operating Income	$15M	-$10M	+251.2%
Net Income	$7M	-$39M	+119.1%